Antibody Engineering: Methods and Protocols

· Methods in molecular biology Книга 248 · Springer Science & Business Media
3,0
1 Ρ€Π΅Ρ†Π΅Π½Π·ΠΈΡ˜Π°
Π•-ΠΊΠ½ΠΈΠ³Π°
562
Π‘Ρ‚Ρ€Π°Π½ΠΈΡ†ΠΈ
ΠžΡ†Π΅Π½ΠΈΡ‚Π΅ ΠΈ Ρ€Π΅Ρ†Π΅Π½Π·ΠΈΠΈΡ‚Π΅ Π½Π΅ сС ΠΏΠΎΡ‚Π²Ρ€Π΄Π΅Π½ΠΈ Β Π”ΠΎΠ·Π½Π°Ρ˜Ρ‚Π΅ повСќС

Π—Π° Π΅-ΠΊΠ½ΠΈΠ³Π°Π²Π°

The exquisite binding specificity of antibodies has made them valuable tools from the laboratory to the clinic. Since the description of the murine hybridoma technology by KΓΆhler and Milstein in 1975, a phenomenal number of mo- clonal antibodies have been generated against a diverse array of targets. Some of these have become indispensable reagents in biomedical research, while others were developed for novel therapeutic applications. The attractiveness of an- bodies in this regard is obviousβ€”high target specificity, adaptability to a wide range of disease states, and the potential ability to direct the host’s immune s- tem for a therapeutic response. The initial excitement in finding Paul Ehrlich’s β€œmagic bullet,” however, was met with widespread disappointment when it was demonstrated that murine antibodies frequently elicit the human anti-murine an- body (HAMA) response, thus rendering them ineffective and potentially unsafe in humans. Despite this setback, advances in recombinant DNA techniques over the last 15–20 years have empowered the engineering of recombinant antibodies with desired characteristics, including properties to avoid HAMA. The ability to p- duce bulk quantities of recombinant proteins from bacterial fermentation also fueled the design of numerous creative antibody constructs. To date, the United States Food and Drug Administration has approved more than 10 recombinant antibodies for human use, and hundreds more are in the development pipeline. The recent explosion in genomic and proteomic information appears ready to deliver many more disease targets amenable to antibody-based therapy.

ΠžΡ†Π΅Π½ΠΈ ΠΈ Ρ€Π΅Ρ†Π΅Π½Π·ΠΈΠΈ

3,0
1 Ρ€Π΅Ρ†Π΅Π½Π·ΠΈΡ˜Π°

ΠžΡ†Π΅Π½Π΅Ρ‚Π΅ ја Π΅-ΠΊΠ½ΠΈΠ³Π°Π²Π°

ΠšΠ°ΠΆΠ΅Ρ‚Π΅ Π½ΠΈ ΡˆΡ‚ΠΎ мислитС.

Π˜Π½Ρ„ΠΎΡ€ΠΌΠ°Ρ†ΠΈΠΈ Π·Π° Ρ‡ΠΈΡ‚Π°ΡšΠ΅

ΠŸΠ°ΠΌΠ΅Ρ‚Π½ΠΈ Ρ‚Π΅Π»Π΅Ρ„ΠΎΠ½ΠΈ ΠΈ Ρ‚Π°Π±Π»Π΅Ρ‚ΠΈ
Π˜Π½ΡΡ‚Π°Π»ΠΈΡ€Π°Ρ˜Ρ‚Π΅ ја Π°ΠΏΠ»ΠΈΠΊΠ°Ρ†ΠΈΡ˜Π°Ρ‚Π° Google Play Books Π·Π° Android ΠΈ iPad/iPhone. Автоматски сС синхронизира со смСтката ΠΈ Π²ΠΈ ΠΎΠ²ΠΎΠ·ΠΌΠΎΠΆΡƒΠ²Π° Π΄Π° Ρ‡ΠΈΡ‚Π°Ρ‚Π΅ онлајн ΠΈΠ»ΠΈ ΠΎΡ„Π»Π°Ρ˜Π½ ΠΊΠ°Π΄Π΅ ΠΈ Π΄Π° стС.
Π›Π°ΠΏΡ‚ΠΎΠΏΠΈ ΠΈ ΠΊΠΎΠΌΠΏΡ˜ΡƒΡ‚Π΅Ρ€ΠΈ
МоТС Π΄Π° ΡΠ»ΡƒΡˆΠ°Ρ‚Π΅ Π°ΡƒΠ΄ΠΈΠΎΠΊΠ½ΠΈΠ³ΠΈ ΠΊΡƒΠΏΠ΅Π½ΠΈ ΠΎΠ΄ Google Play со ΠΊΠΎΡ€ΠΈΡΡ‚Π΅ΡšΠ΅ Π½Π° Π²Π΅Π±-прСлистувачот Π½Π° ΠΊΠΎΠΌΠΏΡ˜ΡƒΡ‚Π΅Ρ€ΠΎΡ‚.
Π•-Ρ‡ΠΈΡ‚Π°Ρ‡ΠΈ ΠΈ Π΄Ρ€ΡƒΠ³ΠΈ ΡƒΡ€Π΅Π΄ΠΈ
Π—Π° Π΄Π° Ρ‡ΠΈΡ‚Π°Ρ‚Π΅ Π½Π° ΡƒΡ€Π΅Π΄ΠΈ со Π΅-мастило, ΠΊΠ°ΠΊΠΎ ΡˆΡ‚ΠΎ сС Π΅-Ρ‡ΠΈΡ‚Π°Ρ‡ΠΈΡ‚Π΅ Kobo, ќС Ρ‚Ρ€Π΅Π±Π° Π΄Π° ΠΏΡ€Π΅Π·Π΅ΠΌΠ΅Ρ‚Π΅ Π΄Π°Ρ‚ΠΎΡ‚Π΅ΠΊΠ° ΠΈ Π΄Π° ја ΠΏΡ€Π΅Ρ„Ρ€Π»ΠΈΡ‚Π΅ Π½Π° ΡƒΡ€Π΅Π΄ΠΎΡ‚. Π‘Π»Π΅Π΄Π΅Ρ‚Π΅ Π³ΠΈ Π΄Π΅Ρ‚Π°Π»Π½ΠΈΡ‚Π΅ упатства Π²ΠΎ Π¦Π΅Π½Ρ‚Π°Ρ€ΠΎΡ‚ Π·Π° помош Π·Π° ΠΏΡ€Π΅Ρ„Ρ€Π»Π°ΡšΠ΅ Π½Π° Π΄Π°Ρ‚ΠΎΡ‚Π΅ΠΊΠΈΡ‚Π΅ Π½Π° ΠΏΠΎΠ΄Π΄Ρ€ΠΆΠ°Π½ΠΈ Π΅-Ρ‡ΠΈΡ‚Π°Ρ‡ΠΈ.